Non-Current Liabilities

Accrued litigation

Boston Scientific Accrued litigation increased by 16.0% to $152.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.6%, from $126.00M to $152.00M. Over 4 years (FY 2020 to FY 2024), Accrued litigation shows a downward trend with a -23.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ4 2015
Last reportedQ3 2025
Metric ID: non_current_liabilities_litigation_reserve_current

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$417.00M$357.00M$264.00M$279.00M$359.00M$174.00M$231.00M$207.00M$209.00M$246.00M$206.00M$129.00M$118.00M$126.00M$177.00M$137.00M$131.00M$152.00M
QoQ Change-14.4%-26.1%+5.7%+28.7%-51.5%+32.8%-10.4%+1.0%+17.7%-16.3%-37.4%-8.5%+6.8%+40.5%-22.6%-4.4%+16.0%
YoY Change-13.9%-51.3%-12.5%-25.8%-41.8%+41.4%-10.8%-37.7%-43.5%-48.8%-14.1%+6.2%+11.0%+20.6%
Range$118.00M$417.00M
CAGR-21.1%
Avg YoY Growth-15.8%
Median YoY Growth-14.0%

Frequently Asked Questions

What is Boston Scientific's accrued litigation?
Boston Scientific (BSX) reported accrued litigation of $152.00M in Q3 2025.
How has Boston Scientific's accrued litigation changed year-over-year?
Boston Scientific's accrued litigation increased by 20.6% year-over-year, from $126.00M to $152.00M.
What is the long-term trend for Boston Scientific's accrued litigation?
Over 4 years (2020 to 2024), Boston Scientific's accrued litigation has grown at a -23.1% compound annual growth rate (CAGR), from $505.00M to $177.00M.